CIK 0000842023
- Large accelerated filer
BIO-TECHNE Corp
Sign in to watch- Ticker
- TECH
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jun 30
- Incorporated
- MN
- Entity type
- Operating
- EIN
- 411427402
- Phone
- +1 612-379-8854
- Business address
- 614 MCKINLEY PLACE NE, MINNEAPOLIS, MN
- Former names
- TECHNE CORP /MN/
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2013-10-31 | Nusse Roeland Director | Grant or award · Stock Option | +4,000 | 4,000 | ||
| 2013-10-31 | OCONNELL HOWARD V Director | Grant or award | +1,000 | 1,000 | ||
| 2013-10-31 | OCONNELL HOWARD V Director | Grant or award · Stock Option | +4,000 | 4,000 | ||
| 2013-08-01 | VERONNEAU MARCEL VP Clinical Controls | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2013-08-01 | REAGAN KEVIN J Senior VP Biotech | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2013-08-01 | MELSEN GREGORY J CFO | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2013-08-01 | Bazan J. Fernando Chief Technical Officer | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2013-08-01 | Bazan J. Fernando Chief Technical Officer | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2013-08-01 | Bazan J. Fernando Chief Technical Officer | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2013-07-01 | VERONNEAU MARCEL VP Clinical Controls | Shares withheld for taxes | −402 | $69.69 | $28K | 34,167 |
| 2013-07-01 | VERONNEAU MARCEL VP Clinical Controls | Exercise or conversion | +567 | $49.43 | $28K | 34,734 |
| 2013-07-01 | VERONNEAU MARCEL VP Clinical Controls | Exercise or conversion · Stock Option | −567 | 0 | ||
| 2013-05-06 | OCONNELL HOWARD V Director | Purchase | +2,361 | $65.00 | $153K | 70,000 |
| 2013-04-01 | Kummeth Charles R. Chief Executive Officer | Grant or award | +15,000 | 15,000 | ||
| 2013-04-01 | Kummeth Charles R. Chief Executive Officer | Grant or award · Stock Option | +65,000 | 65,000 | ||
| 2013-04-01 | Kummeth Charles R. Chief Executive Officer | Grant or award · Stock Option | +50,000 | 50,000 | ||
| 2012-12-18 | MELSEN GREGORY J CEO | Exercise or conversion | +1,012 | $49.43 | $50K | 1,438 |
| 2012-12-18 | MELSEN GREGORY J CEO | Exercise or conversion · Stock Option | −1,012 | 0 | ||
| 2012-11-30 | MELSEN GREGORY J CEO | Grant or award · Stock Option | +15,000 | 15,000 | ||
| 2012-10-27 | OCONNELL HOWARD V Director | Gift | −20,000 | $71.65 | $1.4M | 67,639 |
Page 73 of 75 · 1,487 trades